Clinical Connection Home
  Welcome To
Clinical Connection
 
Be notified of new studies!
Find Clinical Trials!
Message Board
Share This Page
Allergy Clinical Trials, Diagnosis, and Treatment
Thank you for your interest in clinical trials for Allergy.

Please click "Search" to find Allergy clinical trials and medical research studies or read below for information on Allergy diagnosis and treatment.

If you receive too many study listings you may enter your zip code to find the locations closest to you.


Any Of These Words:
OR
All Of These Words
OR
This Exact Phrase:
AND
Zip Code:
Distance:
Search results will appear below.
Your search returned 1 studies:


Seasonal Allergies - Tomball TX
Browse All Available Clinical Trials

Join Now to be Notified of New Clinical Trials

View Information and Clinical Trials for Other Conditions


Allergy

An allergy is an abnormal, acquired sensitivity to a given substance, including pollen, drugs, or numerous environmental triggers. The term was coined by the Viennese pediatrician Clemens von Pirquet in 1906 after noting that some of his patients were hypersensitive to normally innocuous entities such as dust, pollen, or certain foods. Pirquet called this phenomenon "allergy", from the Greek words allos meaning "other" and ergon meaning "work".

Historically, all forms of hypersensitivity were classified as allergies, and all thought to be caused by an improper activation of the antibody class called Immunoglobulin E - Teruka and Kimishige Ishizaka were among the first to isolate and describe IgE in the 1960s.

Later, it became clear that several different disease mechanisms were implicated, with the common link between these varying hypersensitivities being a disordered activation of the immune system in one way or another. A new classification scheme was designed by P. Gell and R. Coombs to reflect what were then rebaptized hypersensitivity reactions. The word "allergy" was then restricted to type I hypersensitivities, which are caused by the classical IgE mechanism.

Type I hypersensitivity is characterised by excessive activation of mast cells and basophils by IgE, resulting in a systemic inflammatory response that can result in symptoms as benign as a runny nose, to life-threatening anaphylactic shock and death.

Knowing any allergies that a patient may have is important in a clinical setting. Full allergy history is taken down when obtaining a medical history of a patient. This ensures that no contradictory treatments are prescribed to the danger of the patient. Physicians in the United States who hold certification by the American Board of Allergy and Immunology (ABAI) have successfully completed an accredited educational program and an evaluation process, including a secure, proctored examination to demonstrate the knowledge, skills, and experience to the provision of patient care in allergy and immunology.

An allergist-immunologist is a physician specially trained to manage and treat asthma and the other allergic diseases. Becoming an allergist-immunologist requires completion of at least nine years of training. After completing medical school and graduating with a medical degree, a physician will then undergo three years of training in internal medicine (to become an internist) or pediatrics (to become a pediatrician). Once physicians have finished training in one of these specialties, they must pass the exam of either the American Board of Pediatrics (ABP) or the American Board of Internal Medicine (ABIM). Internists or pediatricians who wish to focus on the subspecialty of allergy-immunology then complete at least an additional two years of study, called a fellowship, in an allergy-immunology training program. Allergist-immunologists who are listed as ABAI-certified have successfully passed the certifying examination of the American Board of Allergy and Immunology (ABAI), following their fellowship.

Current Research

For current research articles click - here

Signs and Symptoms

Allergy is a local or systemic inflammatory response to allergens. Local symptoms are:
  • Nose: swelling of the nasal mucosa (allergic rhinitis)
  • Eyes: redness and itching of the conjunctiva (allergic conjunctivitis)
  • Airways: bronchoconstriction, wheezing and dyspnoea, sometimes outright attacks of asthma, in severe cases the airway constricts due to swelling known as anaphylaxis.
  • Ears: feeling of fullness, possibly pain, and impaired hearing due to the lack of eustachian tube drainage.
  • Skin: various rashes, such as eczema, hives (urticaria) and contact dermatitis.
  • Head: while not as common, headaches are seen in some with environmental or chemical allergies.
Systemic allergic response is also called anaphylaxis; multiple systems can be affected including the digestive system, the respiratory system, and the circulatory system. Depending of the rate of severity, it can cause cutaneous reactions, bronchoconstriction, edema, hypotension, coma and even death. This type of reaction can be triggered suddenly or the onset can be delayed. The severity of this type of allergic response often requires injections of epinephrine, sometimes through a device known as the Epi-Pen auto-injector. The nature of anaphylaxis is such that the reaction can seemingly be subsiding, but may recur throughout a prolonged period of time.

Allergic rhinitis afflicts 20% of the US population. Also known as hayfever, symptoms can be in response to airborne pollen. Asthmatics are often allergic to dust mites. Apart from ambient allergens, allergic reactions can be result from foods, insect stings and reactions to medications.

Diagnosis

Once a diagnosis of asthma, rhinitis, anaphylaxis, or some other allergic disease has been made, there are several methods for finding out what the patient is allergic to.

Skin Testing

For assessing the presence of specific IgE antibodies, allergy skin testing, when possible, is the preferred method in comparison with various blood allergy tests because it is more sensitive and specific, simpler to use, and less expensive. Different blood allergy testing methods are currently available; the radioallergosorbent test (RAST) test method, which uses radioactive isotopes for testing, has largely been replaced by more modern methods.

The typical method of diagnosis and monitoring of Type I Hypersensitivity is skin testing, also known as "puncture testing" and "prick testing" due to the series of tiny puncture or pricks made into the patient's skin. Small amounts of suspected allergens and/or their extracts (pollen, grass, mite proteins, peanut extract, etc.) are introduced to sites on the skin marked with pen or dye (the ink/dye should be carefully selected, lest it cause an allergic response itself). A small plastic or metal device is used to puncture or prick the skin. Sometimes, the allergens are injected "intradermally" into the patient's skin, with a needle and syringe. Common areas for testing include the inside forearm and the back. If the patient is allergic to the substance, then a visible inflammatory reaction will usually occur within 30 minutes. This response will range from slight reddening of the skin to a full-blown hive (called "wheal and flare") in more sensitive patients.

After performing the skin test and receiving results, the nurse may apply a skin cream, perhaps a corticosteriod cream, to the test area to reduce discomfort (such as itching and inflammation).

Considerations with Skin Test

The skin prick test is the most preferred means of testing because of its simplicity, economic implications and its accuracy relative to the other tests available.

Interpretation of the results of the skin prick test is normally done by allergists on a scale of severity, with +/- meaning borderline reactivity, and 4+ being a large reaction. Increasingly, allergists are measuring and recording the diameter of the wheal and flare reaction.

Theoretical concerns include how to choose patients, interpret results, and maintain safety. If a serious life threatening anaphylactic reaction has brought a patient in for evaluation, some allergists will prefer an initial blood test prior to performing the skin prick test. Skin tests may not be an option if the patient has widespread skin disease or has not avoided antihistamines for several days. Additionally, some patients may believe they have determined their own allergic sensitivity from observation, but a skin test has been shown to be much better than patient observation to detect allergy.

Some people may display a small, delayed reaction that can occur up to 6 hours after application of the allergen and last up to 72 hours. It is often easily treated with anti-inflammatory creams. Interpretation by well-trained allergists is often guided by relevant literature which can offer calculation of 95% and 99% predicted probabilities using logistic regression revealed predictive decision points.

Another consideration with the application of previously un-encountered insect venom allergen is the theoretical possibility that this minute exposure can actually sensitize one to these allergen, causing the inception of a new sensitivity, but such a development is almost unheard of in clinical experience[citation needed]. For all these reasons skin testing should be offered by individuals with advanced training in the diagnosis and treatment of allergic disease.

Blood testing

This kind of testing is also known as a "total IgE level". This method measures the total amount of IgE contained within the patient's serum. This can be determined through the use of radiometric and colormetric immunoassays. The levels of IgE specific to certain allergens can be measured through use of various blood allergy test methods. The radioallergosorbent test (RAST) method uses radioactive isotopes for the measuring process. Other newer methods use colorimetric or fluorometric technology. Some "screening" test methods are intended to provide qualitative test results, giving a "yes" or "no" answer in patients with suspected allergic sensitization. One such method has a sensitivity of about 70.8% and a positive predictive value of 72.6% according to a large study.

A low total IgE level is not useful to rule out sensitization to common inhalant allergens. Statistical methods, such as ROC curves, predictive value calculations, and likelihood ratios have been used to examine the relationship of various testing methods to each other. These methods have shown that patients with a high total IgE have a high probability of allergic sensitization, but further investigation with specific allergy tests for a carefully chosen allergens is often warranted.

Treatment

There have been enormous improvements in mainstream medical treatments developed by allergists. Recently, advances in anaphylaxis and hypersensitivity reactions to foods, drugs, and insects and in allergic skin disease include: the identification of food proteins to which IgE binding is associated with severe reactions, improvements in skin prick test predictions; evaluation of the atopy patch test; and advances in yellow jacket sting outcomes predictions and a rapidly disintegrating epinephrine tablet and development of low-allergen foods, and anti-IL-5 for eosinophilic diseases.

Immunotherapy

Immunotherapy, once called hyposensitization, is a treatment in which the patient is gradually vaccinated with progressively larger doses of the allergen in question. This can either reduce the severity or eliminate hypersensitivity altogether. It relies on the progressive skewing of IgG ("the blocking antibody") production, as opposed to the excessive IgE production seen in hypersensitivity type I cases.

Many national and international guidelines, including the Allergic Rhinitis and its Impact on Asthma guidelines, first published in 2001 and revised in 2007, confirm the clinical efficacy of injection immunotherapy in rhinitis and asthma, as well as the safety, provided that recommendations are followed.

Studies have demonstrated the long-term efficacy and the preventive effect of immunotherapy in reducing the development of new allergy.

A randomized trial demonstrated that injection immunotherapy reduces the risk of developing asthma.

Recent meta-analyses confirm its efficacy in allergic rhinitis in children and in asthma.

A second form of immunotherapy involves the intravenous injection of monoclonal anti-IgE antibodies. These bind to free and B-cell IgE, signalling such sources for destruction. They do not bind to IgE already bound to the Fc receptor on basophils and mast cells as this would stimulate the allergic inflammatory response. The first agent in this class is omalizumab.

Unproven or Ineffective Treatments

An experimental treatment, enzyme potentiated desensitization (EPD), has been tried for decades but is not generally accepted as effective.[15] EPD uses dilutions of allergen and an enzyme, beta-glucuronidase, to which T-regulatory lymphocytes are supposed to respond by favouring desensitization, or down-regulation, rather than sensitization. EPD has also been tried for the treatment of autoimmune diseases but again is not FDA approved or of proven effectiveness.

Pharmacotherapy

Several antagonistic drugs are used to block the action of allergic mediators, or to prevent activation of cells and degranulation processes. They include antihistamines, cortisone, dexamethasone, hydrocortisone, epinephrine (adrenaline), theophylline and cromolyn sodium. Antileukotrienes, such as montelukast (Singulair) or zafirlukast (Accolate), have also been FDA approved for allergic diseases. Anticholinergics, decongestants, mast cell stabilizers, and other compounds (some of which might impair eosinophil chemotaxis) are also commonly used. These drugs help alleviate the symptoms of allergy but play little role in chronic alleviation of the disorder. They can play an imperative role in the acute recovery of someone suffering from anaphylaxis, which is why those allergic to bee stings, peanuts, nuts, and shellfish often carry an device for giving an emergency injection of epinephrine with them at all times.

Alternative therapies

In alternative medicine, a number of treatment modalities are considered effective by its practitioners in the treatment of allergies, particularly naturopathic, herbal medicine, homeopathy, traditional Chinese medicine and kinesiology, despite the lack of approval by the United States Food and Drug Administration. These modalities are frequently offered as treatment for those seeking additional help when mainstream medicine has failed to provide adequate relief from allergy symptoms[citation needed]. However, mainstream physicians[attribution needed] maintain that these claims lack a scientific basis and warn that the efficacy of such treatments is only supported by anecdotal evidence.

Systematic literature searches conducted by the Mayo Clinic through 2006 in hundreds of articles studying mutliple conditions including asthma, and upper respiratory tract infection showed no effectiveness, and no difference compared with placebo and stated that based on rigorous clinical trials of all types of homeopathy for childhood and adolescence ailments there is no convincing evidence

Pathophysiology

The pathophysiology of allergic responses can be divided into two phases; firstly the acute response, which can then either subside or progress into a "late phase response" which can substantially prolong the symptoms of a response.

Acute Response

A type I hypersensitivity reaction against an allergen via the normal humoral response against a foreign body results after plasma cells secrete IgE as opposed to other classes of immunoglobulins such as IgM (against novel antigens) or IgG (against immunized antigens). IgE binds to Fc epsilon R1 (high affinity) receptors on the surface of mast cells and basophils, both involved in the acute inflammatory response. The class switch in the plasma cell leading to IgE is tightly regulated by the immune system. CD45 plays a critical regulatory role in receptor signaling through its protein tyrosine phosphatase and Janus kinase (JAK) phosphatase activities. IL-4 is the primary interleukin which induces switch recombination. Class switch recombination to IgE can also be triggered by the TH2 cytokine IL-13. CD45 is able to function as JAK phosphatase in human B cells, and this activity is directly associated with negative regulation of the class switch recombination to IgE. IgE-bearing epidermal dendritic cells have also been found.

When IgE is first secreted it binds to the Fc receptors on a mast cell or basophil, and such an IgE-coated cell is said to be sensitized to the allergen in question. A later exposure by the same allergen causes reactivation of these IgE, which then signals for the degranulation of the sensitized mast cell or basophil. There is now strong evidence that mast cells and basophils require costimulatory signals for degranulation in vivo, derived from GPCRs such as chemokine receptors. These granules release histamine and other inflammatory chemical mediators (cytokines, interleukins, leukotrienes, and prostaglandins) into the surrounding tissue causing several systemic effects, such as vasodilation, mucous secretion, nerve stimulation and smooth muscle contraction. This results in the previously described symptoms of rhinorrhea, itchiness, dyspnea, and anaphylaxis. Depending on the individual, allergen, and mode of introduction, the symptoms can be system-wide (calliscal anaphylaxis), or localised to particular body systems (for example, asthma to the respiratory system; eczema to the dermis).

Late-Phase Response

After the chemical mediators of the acute response subside, late phase responses can often occur. This is due to the migration of other leukocytes such as neutrophils, lymphocytes, eosinophils and macrophages to the initial site. The reaction is usually seen 4-6 hours after the original reaction and can last from 1-2 days. Cytokines from mast cells may also play a role in the persistence of long-term effects. Late phase responses seen in asthma are slightly different from those seen in other allergic responses.

Basis and Cause

The exact cause of the IgE malfunctions that result in allergic reactions are not always apparent[citation needed], however, and several arguments[attribution needed] from genetic-basis, environmental-basis and intermediate proponents exist with varying validity and acceptance.

Genetic basis

There is much evidence[citation needed] to support the genetic basis of allergy. Allergic parents are more likely to have allergic children, and their allergies are likely to be stronger than those from non-allergic parents. However some allergies are not consistent along genealogies with parents being allergic to peanuts, but having children allergic to ragweed, or siblings not sharing the same allergens.

Ethnicity has also been shown to play a role in some allergies. Interestingly, in regard to asthma, it has been suggested[attribution needed] that different genetic loci are responsible for asthma in people of Caucasian, Hispanic, Asian, and African origins. It has also been suggested[attribution needed] that there are both general atopy genes and tissue-specific allergy genes that target the allergic response to specific mucosal tissues. Potential disease associated alleles include both coding region variation and SNPs. Caucasians display the greatest incidence of asthma.

Relationship with parasites

Some recent research has also begun to show that some kinds of common parasites, such as intestinal worms (e.g. hookworms), secrete immunosuppressant chemicals into the gut wall and hence the bloodstream which prevent the body from attacking the parasite. This gives rise to a new slant on the "hygiene hypothesis" — that co-evolution of man and parasites has in the past led to an immune system that only functions correctly in the presence of the parasites. Without them, the immune system becomes unbalanced and oversensitive. Gutworms and similar parasites are present in untreated drinking water in undeveloped countries, and in developed countries until the routine chlorination and purification of drinking water supplies. This also coincides with the time period in which a significant rise in allergies has been observed.[citation needed] So far, there is only sporadic evidence to support this hypothesis — one scientist who suffered from seasonal allergic rhinitis (hayfever) infected himself with gutworms and was immediately 'cured' of his allergy with no other ill effects. Full clinical trials have yet to be performed however. It may be that the term 'parasite' could turn out to be inappropriate, and in fact a hitherto unsuspected symbiosis is at work.

Increasing Prevalence

There has been a notable increase in the commonness of allergies in the past decades, and there are multiple hypotheses explaining this phenomenon. This is in part because we know what they are, in contrast to earlier humans who would think that the symptoms pointed towards a non-important illness.

Increasing Use of hemicals

One theory is the exponential use and abuse of chemicals in affluent nations since the second world war. Vast numbers of chemicals are introduced into our indoor and outdoor environments with little or no testing[citation needed] regarding their toxicity to living beings. Many believe[attribution needed] that air quality is getting worse rather than better, particularly if one considers indoor air quality as well as outdoor. (Indoor air quality has become significantly worse since building codes changed in the 1970s to make buildings more air-tight to conserve energy. This affects buildings built since that time.) Adverse reactions to toxins vary considerably from one person to another, and can involve extremes in symptoms including the neurological and endocrine systems as well as the more commonly recognized allergy symptoms listed above.

In 2004, a joint Swedish-Danish research team found a very strong link between allergies in children and the phthalates DEHP and BBzP, commonly used in PVC. Allergies are also viewed by some medical practitioners as a negative consequence of the use and abuse of antibiotics and vaccinations. This mainstream Western approach to treatment and prevention of infectious disease has been used in the more affluent world for a longer period of time than in the rest of the world, hence the much greater commonality of allergies there. It is hypothesized that use of antibiotics and vaccination affect the immune system, and that allergies are a dysfunctional immune response.

The "Hygiene Hypothesis"

The hygiene hypothesis maintains that children in more affluent countries are leading a cleaner and cleaner life in modern times (less exposure to dirt, extra use of disinfectants, etc), their immune systems have less exposure to parasites and other pathogens than children in other countries or in decades past. Their immune systems may, therefore, have many "loaded guns", cells which might have targeted, say, the intestinal worms that no longer cause trouble in affluent neighbourhoods. Having no reasonable target, these cells inadvertently become activated by environmental antigens that might only cause minor reactions in others. It is the symptoms of this exaggerated response that is seen as the allergic reaction.

Many common allergies such as asthma have seen huge increases in the years since World War II, and many studies[citation needed] appear to show a correlation between this and the increasingly affluent and clean lifestyles in the West. This is supported by studies[citation needed] in less developed countries that do not enjoy western levels of cleanliness, and similarly do not show western levels of incidences of asthma and other allergies. During this same period, air quality, at one time considered the "obvious" cause of asthma, has shown a considerable improvement. This has led some researchers to conclude that it is our "too clean" upbringing that is to blame for the lack of immune system stimulation in early childhood.

Evidence for the hygiene hypothesis appears to be mounting more so then for the chemical hypothesis. Such data is still open to interpretation. Day care for children offers protective effects against asthma, as do early episodes of viral infection. Children raised on a farm also have a decreased atopy. Exposure to endotoxin and other components of bacteria may reduce atopic diseases.

Environmental endotoxin showed a strong protection against hay fever and allergy. Endotoxin exposure reduces peripheral blood leukocytes release of inflammatory cytokines after lipopolysaccharide, including cytokines such as tumor necrosis factor alpha, interferon-gamma, interleukin-10, and interleukin-12 . Toll-like receptors are thought to be involved. This is the basis for the new DNA vaccine being developed by Peter Creticos and others at the Johns Hopkins Division of Allergy.

One supporting fact[citation needed] is that many Chinese will develop hay fever after moving into the USA for three or more years. However, contradictory examples also exist.

Common Allergens

In addition to foreign proteins found in foreign serum (from blood transfusions) and vaccines, common allergens include:
  • Plant pollens (Hay fever):
    • Rye grass
    • Ragweed
    • Timothy grass
    • Birch trees
    • Juniper trees
  • Mold spores
  • Drugs:
    • Penicillins
    • Sulfonamides
    • Salicylates (also found naturally in numerous fruits)
    • Local anaesthetics
  • Foods (food allergy):
    • Nuts (2 separate cases)
      • Peanuts
      • Nuts
    • Sesame
    • Seafood
    • Celery
    • Egg (typically albumen, the white)
    • Peas, beans, peanuts, soybeans and other legumes
    • Soy
    • Milk
    • Wheat
    • Maize (corn)
    • Pumpkin
  • Insect stings:
    • Bee sting venom
    • Wasp sting venom
  • Animal products (animal allergy):
    • Animal hair and dander (see also: Cat allergy)
    • Cockroach calyx
    • Dust mite excretion
  • Other
    • Latex
    • Metal


(adapted from Wikipedia, the free encyclopedia http://en.wikipedia.org/wiki/Allergies)





Findings From Current Research

A New Mechanism Regulating the Initiation of Allergic Airway Inflammation

Authors: Kiss A, Montes M, Susarla S, Jaensson EA, Drouin SM, Wetsel RA, Yao Z, Martin R, Hamzeh N, Adelagun R, Amar S, Kheradmand F, Corry DB.

From the Departments of Medicine.

BACKGROUND: The earliest immune events induced by allergens are poorly understood, yet are likely essential to understanding how allergic inflammation is established. OBJECTIVE: We sought to describe the earliest signaling events activated by allergen and determine their significance to allergic inflammation. METHODS: A fungal-associated allergenic proteinase (FAP) or ovalbumin was administered once intranasally to wild-type mice to determine their ability to induce allergy-associated genes and initiate allergic lung inflammation. Mice deficient in recombinase activating gene 1, C3a, the C3a anaphylatoxin receptor, and MyD88 were challenged similarly to understand the requirement of these molecules and T and B cells for allergic inflammation. Adoptive T-cell transfer experiments were further performed to determine whether signal transducer and activator of transcription 6 (STAT6) was required for cell recruitment and allergic inflammation. RESULTS: FAP, but not ovalbumin, induced eosinophilic airway inflammation and lung IL-4 production in the absence of adaptive immune cells after the transcriptional induction of allergy-specific airway chemokines. Allergen-mediated chemokine secretion and innate allergic lung inflammation occurred in the absence of STAT6, recombinase activating gene 1, C3a, C3a anaphylatoxin receptor, Toll-like receptor 4, and MyD88 but required intact proteinase activity. Furthermore, FAP induced recruitment of T(H)2 cells and eosinophils to lungs independently of STAT6, which was previously thought to be required for T(H)2 cell homing. CONCLUSION: FAP induces allergic lung inflammation through a previously unrecognized innate immune signaling mechanism. CLINICAL IMPLICATIONS: These findings reveal a new paradigm for understanding how allergic inflammation begins and suggest novel possibilities for the prevention and treatment of allergic diseases, such as asthma.

Journal: J Allergy Clin Immunol. 2007 Jun 1
Adapted from PubMed; click here to access full journal article.




Which Diuretics are Safe and Effective for Patients with a Sulfa Allergy?

Authors: Healy R, Jankowski TA, Crownover B.

University of Washington, Seattle; Alaska Family Medicine Residency, Anchorage, AK USA.

Diuretics that do not contain a sulfonamide group (eg, amiloride hydrochloride, eplerenone, ethacrynic acid, spironolactone, and triamterene) are safe for patients with an allergy to sulfa. The evidence is contradictory as to whether a history of allergy to sulfonamide antibiotics increases the risk of subsequent allergic reactions to commonly used sulfonamide-containing diuretics (eg, carbonic anhydrase inhibitors, loop diuretics, and thiazides) (strength of recommendation: C, based on case series and poor quality case-control and cohort studies).

Journal: J Fam Pract. 2007 Jun;56(6):488-90.
Adapted from PubMed; click here to access full journal article.




Do Indoor Chemicals Promote Development of Airway Allergy?

Authors: Nielsen GD, Larsen ST, Olsen O, Løvik M, Poulsen LK, Glue C, Wolkoff P.

National Institute of Occupational Health Denmark, Copenhagen, Denmark.

Allergic asthma has increased worldwide in the industrialized countries. This review evaluates whether the major groups of indoor chemical exposures possess allergy-promoting (adjuvant) effects; formaldehyde was excluded, because of the size of the literature. Volatile organic compounds (VOCs) are used as an example of gases and vapors. The precipitation of asthmatic symptoms by VOC exposures is probably because of VOC levels considerably above typical indoor levels, or VOCs may be a surrogate for exposure to allergens, combustion products or dampness. Indoor particles possessed adjuvant effects in animal studies and allergy-promoting effects in humans. Quaternary ammonium compounds may possess adjuvant effects in animal studies and promoted sensitization in humans in occupational settings. The use of cleaning agents, anionic and non-ionic surfactants are not considered to possess an important adjuvant effect in the general population. Regarding phthalate exposures, results from animal and epidemiological studies were found to be discordant. There is little evidence that the indoor chemicals evaluated possess important adjuvant effects. If buildings are kept clean, dry and free of combustion products, the important question may be would it be profitable to look for lifestyle factors and non-chemical indoor exposures in order to abate airway allergy? Practical Implications Indoor chemicals (pollutants) have been accused to promote development of airway allergy by adjuvant effects. In this review, we evaluated the scientific literature and found little support for the supposition that indoor chemicals posses important adjuvant effects. This rises the question: would it be profitable for abatement of airway allergy to look for non-chemical indoor exposures, including lifestyle factors, and exposures to allergens, microorganisms, including vira, and their interactions?

Journal: Indoor Air. 2007 Jun;17(3):236-55.
Adapted from PubMed; click here to access full journal article.




Risk Factors for Allergy Due to the Two-Spotted Spider Mite (Tetranychus Urticae) Among Table Grape Farm Workers

Authors: Jeebhay MF, Baatjies R, Chang YS, Kim YK, Kim YY, Major V, Lopata AL.

Occupational and Environmental Health Research Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

Background: Recent studies have reported an increased prevalence of respiratory symptoms among farm workers. The aim of this study was to identify risk factors associated with spider mite allergy among table grape farm workers. Methods: A cross-sectional study of 207 workers in table grape farms was conducted. Skin prick tests used extracts of 8 common aeroallergens, grape mould (Botrytis cinerea) and Tetranychus urticae. Specific IgE to T. urticae was quantified using ImmunoCAP (Phadia). Erythrocyte cholinesterase levels were determined using the Test-mate ChE Cholinesterase Test System (model 460). Results: The average duration of employment of workers was 10 years and 12% were pesticide crop sprayers. Work-related wheeze (26%), ocular-nasal (24%) and urticaria/skin symptoms (14%) were more prevalent in the orchards. The prevalence of sensitization (skin prick test) was highest to T. urticae (22%) followed by house dust mite (16%), with 25% being atopic. The prevalence of allergy to T. urticae (skin reactivity and work-related symptoms) was 9.5%, with respiratory allergy (6%) more common than skin allergy (3%). Work-related ocular-nasal (OR = 4.9) and skin (OR = 3.7) symptoms were more commonly reported by pesticide crop sprayers. Workers with T. urticae-allergic rhino-conjunctivitis and probable asthma were more likely to be atopic, spray pesticides and have low (<30 U/g hemoglobin) erythrocyte cholinesterase levels. Conclusions: This study demonstrated that spider mite, T. urticae, is an important outdoor allergen among table grape farm workers. The increased risk of spider mite allergy appears to be related to high pesticide exposure among crop sprayers. Copyright (c) 2007 S. Karger AG, Basel.

Journal: Int Arch Allergy Immunol. 2007 May 25;144(2):143-149
Adapted from PubMed; click here to access full journal article.




Contact Allergy in Oral Disease

Authors: Torgerson RR, Davis MD, Bruce AJ, Farmer SA, Rogers RS.

From the Department of Dermatology and the Division of Biostatistics (S.A.F.), Mayo Clinic.

BACKGROUND: The role of contact allergy in oral cavity disease processes is unknown. OBJECTIVE: We sought to determine the prevalence of contact allergy to flavorings, preservatives, dental acrylates, medications, and metals in patients with oral disease. METHODS: Patients were tested with an 85-item oral antigen screening series. Data were analyzed retrospectively. RESULTS: We evaluated 331 patients with burning mouth syndrome, lichenoid tissue reaction, cheilitis, stomatitis, gingivitis, orofacial granulomatosis, perioral dermatitis, and recurrent aphthous stomatitis. Positive patch test results were identified in 148 of the 331 patients; 90 patients had two or more positive reactions. Allergens with the highest positive reaction rates were potassium dicyanoaurate, nickel sulfate, and gold sodium thiosulfate. Of the 341 positive patch test reactions, 221 were clinically relevant. LIMITATIONS: No follow-up data were available in this retrospective analysis. CONCLUSION: The positive and relevant allergic reactions to metals, fragrances, and preservatives indicated that contact allergy may affect oral disease.

Journal: J Am Acad Dermatol. 2007 May 24
Adapted from PubMed; click here to access full journal article.




Food Intolerance and Childhood Asthma: What is the Link?

Authors: Beausoleil JL, Fiedler J, Spergel JM.

Division of Allergy and Immunology, The Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

Food allergies and asthma are increasing worldwide. It is estimated that approximately 8% of children aged <3 years have food allergies. Foods can induce a variety of IgE-mediated, cutaneous, gastrointestinal, and respiratory reactions. The most common foods responsible for allergic reactions in children are egg, milk, peanut, soy, fish, shellfish, and tree nuts. Asthma alone as a manifestation of a food allergy is rare and atypical. Less than 5% of patients experience wheezing without cutaneous or gastrointestinal symptoms during a food challenge. In addition to acute respiratory symptoms, a food allergy may also induce airway hyper-responsiveness beyond the initial reaction. This process can occur in patients who do not demonstrate a decrease in lung function during the reaction. Inhalation of aerosolized food particles can cause respiratory symptoms in selected food-allergic individuals, particularly with fish and shellfish during cooking and aerosolization. However, this has not been demonstrated with the smelling of, or casual contact with, peanut butter. Rarely, food additives such as sulfating agents can cause respiratory reactions. This reaction occurs primarily in patients with underlying asthma, particularly in patients with more severe asthma. In contrast, there is no convincing evidence that tartrazine or monosodium glutamate can induce asthma responses. Although food-induced asthma is rare, it is common for patients and clinicians to perceive that food can trigger asthma. Avoidance of specific foods or additives has not been shown to improve asthma, even in patients who may perceive that a particular food worsens their asthma.However, patients with underlying asthma are more likely to experience a fatal or near-fatal food reaction. Food reactions tend to be more severe or life threatening when they involve the respiratory tract. The presence of a food allergy is a risk factor for the future development of asthma, particularly for children with sensitization to egg protein.The diagnosis of a food allergy includes skin or in vitro testing as an initial study when the history suggests food allergy. While negative testing generally rules out a food allergy, positive testing should be followed by a food-challenge procedure for a definitive diagnosis. The CAP-RAST FEIA (CAP-radioallergosorbent test [RAST] fluoroenzyme immunoasssay system [FEIA]) is an improved in vitro measure that in some cases may decrease the need for food challenges. However, similar to skin testing and the RAST, there is good sensitivity but poor specificity, such that specific challenges are often warranted.

Journal: Paediatr Drugs. 2007;9(3):157-163
Adapted from PubMed; click here to access full journal article.




Allergen Immunotherapy in a Patient with Human Immunodeficiency Virus: Effect on T-cell Activation and Viral Replication

Authors: Randhawa IS, Junaid I, Klaustermeyer WB.

UCLA West Los Angeles VA Medical Center, Los Angeles, California 90073, USA. docrandhawa@yahoo.com

BACKGROUND: Allergen immunotherapy is a major therapeutic modality in the treatment of allergic rhinitis. However, with T-cell activation potential, its role in patients with human immunodeficiency virus (HIV) was theoretically limited. OBJECTIVE: To report the results of allergen immunotherapy in a patient with HIV treated with highly active antiretroviral therapy (HAART). METHODS: A 44-year-old man with a history of HIV did not respond to medical therapy for allergic rhinitis. His HIV status was well controlled with HAART. Owing to the severity of his allergic rhinitis symptoms, he accepted the risk of allergy immunotherapy despite the unknown effect of immunotherapy in patients with HIV. RESULTS: After 6 weeks of weekly immunotherapy injections, his viral load remained undetectable and his CD4 cell count changed from 540 to 570 cells/microL. After 16 weeks of weekly immunotherapy, his viral load increased to 10,900 copies/mL, and his CD4 cell count increased to 665 cells/microL. After 24 weeks of weekly immunotherapy, his viral load returned to an undetectable level, and his CD4 cell count stabilized at 356 cells/microL. Despite his notable change in HIV status, he continues to receive the same HAART. He currently continues en route to maintenance immunotherapy. CONCLUSIONS: The effect of allergen immunotherapy on HIV infection has not been previously reported. A concern remains that any form of immunotherapy may negatively affect HIV disease progression. This case illustrates that weekly allergen immunotherapy may have induced limited T-cell proliferation and a modest increase in RNA viral load, which resolved with continuation of HAART.

Journal: Ann Allergy Asthma Immunol. 2007 May;98(5):495-7
Adapted from PubMed; click here to access full journal article.




Join Now - Become a free member and get notified about studies in your area when they become available.

Browse Our Current Studies - Look over all of our current studies being conducted throughout the United States.

View Information and Clinical Trials for Other Conditions - Access all of our health-related content.
Depression - NATIONWIDE
in NATIONWIDE,


Asthma in African Americans - NATIONWIDE
in NATIONWIDE,


Memory Loss / Alzheimer's Disease - Los Alamitos / Long Beach CA
in Los Alamitos, CA


Memory Loss / Alzheimer's Disease - Encino CA
in Los Alamitos, CA


Memory Loss / Alzheimer's Disease - Newport Beach CA
in Los Alamitos, CA


Diabetes (Insulin Delivery) - NATIONWIDE
in NATIONWIDE,


Depression - Virginia Beach VA
in Virginia Beach, VA


Migraine - Virginia Beach VA
in Virginia Beach, VA


Bipolar Depression - Norristown PA
in Norristown, PA


Adolescent Depression - Virginia Beach VA
in Virginia Beach, VA


Major Depression - New York NY
in New York, NY


Bipolar Depression - New York NY
in New York, NY


Generalized Anxiety Disorder - New York NY
in New York, NY


Are You Ready to Quit Smoking? - Menlo Park CA
in Menlo Park, CA


Psoriasis - Baltimore MD
in Baltimore, MD


Migraine- Virginia Beach VA
in Virginia Beach, VA


Osteoarthritis - Virginia Beach VA
in Virginia Beach, VA


Genital Warts - NATIONWIDE
in NATIONWIDE,


Diabetic Neuropathy - DeLand FL
in DeLand , FL


Healthy Volunteers (Sleep Disorders) - DeLand FL
in DeLand, FL


Atrial Fibrillation (Lovaza) - NATIONWIDE
in NATIONWIDE,


ADHD in Children and Adolescents - NATIONWIDE
in NATIONWIDE,


Overweight Healthy Volunteers - Baltimore MD
in Baltimore, MD


B-Cell Lymphoma - NATIONWIDE
in NATIONWIDE,


Treatment Resistant Depression - NATIONWIDE
in NATIONWIDE,


Brain Tumors and Brain Cancers - NATIONWIDE
in NATIONWIDE,


 


© 1998-2008 Clinical Trials Home | Links | Terms And Conditions | Sitemap | Suggestion/Feedback
All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted nationwide.
ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.